Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 12, 2010, Pages 1531-1535

  Van Den Berge, M ^a   Luijk, B ^b   Bareille, P ^c   Dallow, N ^c   Postma, D S ^b   Lammers, J W J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adenosine 5 monophosphate; Airway hyperresponsiveness; Asthma; ENO; Fluticasone furoate; Fluticasone propionate

Indexed keywords

ADENOSINE PHOSPHATE; CORTICOSTEROID; FLUTICASONE FUROATE; FLUTICASONE PROPRIONATE; NITRIC OXIDE; PLACEBO; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HEART PALPITATION; HUMAN; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ADENOSINE MONOPHOSPHATE; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXHALATION; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS;

EID: 78349264228     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02414.x     Document Type: Article

References (14)

1. Holgate ST,. Pathogenesis of asthma. Clin Exp Allergy 2008; 38: 872 -897.
2. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, OByrne P, Barnes PJ, etal. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405 -1411.
3. Meijer RJ, Kerstjens HAM, Arends LR, Kauffman HF, Koeter GH, Postma DS,. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999; 54: 894 -899.
4. Van den Berge M, Meijer RJ, Kerstjens HAM, De Reus DM, Koeter GH, Kauffman HF, etal. PC(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med 2001; 163: 1546 -1550.
5. Van den Berge M, Kerstjens HAM, Meijer RJ, De Reus DM, Koeter GH, Kauffman HF, etal. Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med 2001; 164: 1127 -1132. (Pubitemid 33052238)
6. Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, OConnor BJ,. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma. J Allergy Clin Immunol 2002; 110: 603 -606.
7. Luijk B, Kempsford RD, Wright AM, Zanen P, Lammers JJ,. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction. Eur Respir J 2004; 23: 559 -564.
8. Salter M, Biggadike K, Matthews JL, West MR, Haase MV, Farrow SN, etal. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 2007; 293: L660 -L667.
9. Polosa R, Rajakulasingam K, Church MK, Holgate ST,. Repeated inhalation of bradykinin attenuates adenosine 5′-monophosphate (AMP) induced bronchoconstriction in asthmatic airways. Eur Respir J 1992; 5: 700 -706.
10. Van den Berge M, Kerstjens HA, De Reus DM, Koeter GH, Kauffman HF, Postma DS,. Provocation with adenosine 5′-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy 2004; 34: 71 -76.
11. Valotis A, Hogger P,. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Respir Res 2007; 8: 54.
12. Breekveldt-Postma NS, Koerselman J, Erkens JA, Van Der Molen T, Lammers JW, Herings RM,. Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf 2008; 17: 411 -422.
13. Kharitonov SA, Barnes PJ,. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000; 16: 781 -792.
14. Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Neighbour H, Engelstatter R, etal. Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study. Chest 2008; 134: 740 -745.